Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK Among Treatment-Naïve Patients With Advanced Lung Adenocarcinoma

PLoS ONE- United States

doi 10.1371/journal.pone.0161081

Full Text

Abstract

Available in

Date

August 12, 2016

Authors

Publisher

Public Library of Science (PLoS)

Related search

PCR-based Detection of EGFR, ALK, KRAS and BRAF Mutations in Russian Patients With Lung Adenocarcinoma: A Single-Center Experience

Neoplasma

Cancer Research

2018

English

Fusion of EML4 and ALK Is Associated With Development of Lung Adenocarcinomas Lacking EGFR and KRAS Mutations and Is Correlated With ALK Expression

English

Preoperative Serum Carcinoembryonic Antigen Levels Are Associated With Histologic Subtype, EGFR Mutations, and ALK Fusion in Patients With Completely Resected Lung Adenocarcinoma

OncoTargets and Therapy

Oncology

Pharmacology

2017

English

Combination of Chemotherapy and Gefitinib as First-Line Treatment for Patients With Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: A Randomized Controlled Trial

International Journal of Cancer

Cancer Research

Oncology

2017

English

PIK3CA Mutations Frequently Coexist With EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup

PLoS ONE

Multidisciplinary

2014

English

Prevalence of KRAS, BRAF, PI3K and EGFR Mutations Among Asian Patients With Metastatic Colorectal Cancer

English

Relationship Between EGFR Mutation and Computed Tomography Characteristics of the Lung in Patients With Lung Adenocarcinoma

English

Chemotherapy Combined With Bevacizumab for the Treatment of Advanced Lung Adenocarcinoma Cancer Harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 Mutations: A Case Report

English

Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients

English

Amanote Research

Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK Among Treatment-Naïve Patients With Advanced Lung Adenocarcinoma

PLoS ONE- United States

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

PCR-based Detection of EGFR, ALK, KRAS and BRAF Mutations in Russian Patients With Lung Adenocarcinoma: A Single-Center Experience

Fusion of EML4 and ALK Is Associated With Development of Lung Adenocarcinomas Lacking EGFR and KRAS Mutations and Is Correlated With ALK Expression

Preoperative Serum Carcinoembryonic Antigen Levels Are Associated With Histologic Subtype, EGFR Mutations, and ALK Fusion in Patients With Completely Resected Lung Adenocarcinoma

Combination of Chemotherapy and Gefitinib as First-Line Treatment for Patients With Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: A Randomized Controlled Trial

PIK3CA Mutations Frequently Coexist With EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup

Prevalence of KRAS, BRAF, PI3K and EGFR Mutations Among Asian Patients With Metastatic Colorectal Cancer

Relationship Between EGFR Mutation and Computed Tomography Characteristics of the Lung in Patients With Lung Adenocarcinoma

Chemotherapy Combined With Bevacizumab for the Treatment of Advanced Lung Adenocarcinoma Cancer Harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 Mutations: A Case Report

Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients